UnitedHealth Group Incorporated (UNH)
Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 479.25
- Book/Share 116.5341
- PB 3.1273
- Debt/Equity 0.8366
- CurrentRatio 0.8229
- ROIC 0.1051
- MktCap 298845219124.0
- FreeCF/Share 19.1322
- PFCF 17.2027
- PE 17.031
- Debt/Assets 0.2542
- DivYield 0.0261
- ROE 0.186
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Deutsche Bank | Buy | Hold | -- | $333 | Oct. 29, 2025 |
| Initiation | UNH | Goldman | -- | Buy | -- | $406 | Oct. 14, 2025 |
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
News
UNH Battles MCR, Optum Bandages: But the Real Wild Card is Washington
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth grapples with a surging MCR as Optum's strength steadies results while Washington's policy moves loom large.
Read More
Why Is UnitedHealth (UNH) Down 7.2% Since Last Earnings Report?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Negative
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
Smart Meter Opinion Editorial: Remote Patient Monitoring Works. UnitedHealthcare's 2026 Rollback Ignores the Evidence, and Patients Will Pay the Price.
Published: November 26, 2025 by: Business Wire
Sentiment: Neutral
TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare's decision to sharply limit remote patient monitoring (RPM) reimbursement beginning January 1, 2026, to heart failure and hypertensive disorders of pregnancy, is a disservice to clinicians, patients, and the healthcare system at large. It contradicts federal momentum to modernize chronic care and misrepresents the weight of current evidence on RPM's clinical value fo.
Read More
Is UNH's Hybrid Care Strategy Reshaping the Health System Playbook?
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
UnitedHealth pushes its hybrid care model forward, merging digital tools with in-person care as it extends this approach across global markets.
Read More
Why Did UNH Stock Lose Half Its Value And What Comes Next?
Published: November 24, 2025 by: Forbes
Sentiment: Negative
UnitedHealth's stock plummeted from over $600 to approximately $310-$320 (nearly 50% down) over the last year, and it's not merely market fluctuations. This decline stems from a significant issue centered around one key metric: the Medical Care Ratio (MCR).
Read More
UnitedHealth: Buy Before The Buybacks Resume
Published: November 20, 2025 by: Seeking Alpha
Sentiment: Positive
While the market fixates on UnitedHealth's buyback pause as a sign of distress, a granular analysis of the balance sheet reveals a highly calculable, yet overlooked, path to deleveraging. Investors are currently pricing in a permanent liquidity crunch due to a $3.3 billion debt repayment shortfall, missing the critical distinction between trapped regulatory capital and actual insolvency. I detail how the divergence in Medicare Star Ratings and strategic PPO exits will restore margins, solve the regulatory capital puzzle, and force the buyback window open sooner than expected.
Read More
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger'
Published: November 19, 2025 by: Market Watch
Sentiment: Negative
America's largest insurer is making sweeping changes to its Medicare Advantage plans to improve profit margins.
Read More
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board
Published: November 18, 2025 by: Forbes
Sentiment: Positive
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
Read More
What Could Ignite UNH Stock's Next Major Rally?
Published: November 18, 2025 by: Forbes
Sentiment: Positive
UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.
Read More
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors
Published: November 18, 2025 by: Business Wire
Sentiment: Neutral
--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront t.
Read More
UnitedHealth's Rally Still Has Legs, Further Margin Recovery Through 2027
Published: November 13, 2025 by: Seeking Alpha
Sentiment: Positive
UNH has highlighted numerous bold strategies with the aim of driving margin recovery through 2027, mostly through raised premiums along with benefit adjustments and targeted plan exits. Despite the potential top-line impact arising from member base contraction, the management already expects these efforts to deliver a more sustainable/ premium member base. This is aided by the recently confirmed four stars award for the 2027 Medicare Advantage plans, allowing them to receive higher annual bonus payments.
Read More
Warren Buffett Has Been a Net Seller for 3 Years, but He's Buying These 3 Stocks
Published: November 13, 2025 by: 24/7 Wall Street
Sentiment: Neutral
Warren Buffett has taken a highly conservative approach to the stock market in recent years.
Read More
Can UnitedHealth Still Claim The Top Spot?
Published: November 12, 2025 by: Forbes
Sentiment: Negative
UnitedHealth Group stock (NYSE: UNH) has declined by 7% over the past month. This downturn is attributed to several significant investor concerns, including rising medical costs within its Medicare Advantage plans, ongoing regulatory and legal scrutiny, and margin pressures in the Optum division.
Read More
2 dividend stocks to turn $100 into $1,000 in 2026
Published: November 12, 2025 by: Finbold
Sentiment: Positive
The ongoing government shutdown is nearing its end, and market optimism is slowly returning as major U.S. indexes climb on renewed hopes for economic stability.
Read More
UnitedHealth Group Incorporated (UNH) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated ( UNH ) UBS Global Healthcare Conference 2025 November 10, 2025 8:45 AM EST Company Participants Julie Murphy Wayne DeVeydt - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. I think we're ready to get going.
Read More
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Read More
UnitedHealth's Q3 Beat Isn't Stopping the Bleed: Hold or Fold Now?
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
UNH's Q3 earnings beat couldn't stop a 9.6% stock slide as rising medical costs and margin strain test investor patience.
Read More
Buy Or Sell United Health Stock?
Published: November 05, 2025 by: Forbes
Sentiment: Neutral
UnitedHealth (UNH) shares have dropped 10% over the last week and are presently trading at $330.83. We believe there are only a few aspects to be wary of in UNH stock, considering its overall Moderate operating performance and financial health.
Read More
UnitedHealth: The Market Is Still Worried, And That's Good For Buyers
Published: November 04, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group is showing solid signs of stabilization after July's capitulation, with Berkshire's investment boosting sentiments and a resilient Q3 performance lending a calming influence. UNH's medical cost ratio improvement and double-digit earnings growth expected by 2027 underpin a positive long-term outlook, despite current margin pressures. Valuation has rebounded near its 10-year average, suggesting near-term consolidation, but 2027 EPS forecasts indicate the opportunity for long-term holders is still nascent.
Read More
UnitedHealth Group Q3: Why Strong Money Holds At $323
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group remains a buy, supported by recent super-investor accumulation and their holding price. Super-investors, including Berkshire Hathaway and Michael Burry, currently hold UNH shares at $323, or 19.8x FWD P/E. Given the business updates provided in the company's Q3 ER, my risk calculus shows a very skewed risk/return profile at this holding P/E.
Read More
UnitedHealth: A Glimmer Of Future Growth Is Still There
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround under new leadership. UNH's new management, led by returning CEO Stephen Hemsley, is focusing on profitability, cost control, and margin improvement through operational turnaround. Despite anticipated Medicare Advantage membership contraction, strategic repricing and AI investments are poised to enhance future profitability and demand.
Read More
The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now
Published: October 30, 2025 by: 24/7 Wall Street
Sentiment: Positive
When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, that should raise more interest.
Read More
Here Are Wednesday's Top Wall Street Analyst Research Calls: United Health, SoFi, Skyworks, Energy Transfer and More
Published: October 29, 2025 by: 24/7 Wall Street
Sentiment: Positive
The futures are trading higher this morning after another stellar day across Wall Street on Tuesday, as all the major indices once again ended higher and continue to print new all-time highs.
Read More
UnitedHealth Group's Recovery in Full Swing: Buy While It's Down
Published: October 29, 2025 by: MarketBeat
Sentiment: Neutral
If UnitedHealth Group's NYSE: UNH stock price implosion was driven by margin, earnings, and capital return concerns, the Q3 results put them to rest.
Read More
UnitedHealth: Strong Long-Term Fundamentals, But Risks Also Exist
Published: October 29, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group has outperformed the S&P 500 since my previous Buy and Strong Buy ratings, delivering 33% and 41% total returns. Following Q3 FY2025 earnings review, UNH remains the most expensive among peers ELV, CNC, and MOH based on valuation multiples. Despite strong long-term fundamentals, current risks include elevated medical costs, potential for lower earnings, and risk of multiple compression.
Read More
UnitedHealth Revenue Rises 12% Amid AI Investments
Published: October 28, 2025 by: PYMNTS
Sentiment: Positive
UnitedHealth Group says tech investments are key to its ongoing turnaround strategy. The insurer announced quarterly earnings Tuesday (Oct. 28) showing consolidated revenues of $113.2 billion, a 12% increase year over year.
Read More
UnitedHealthcare May Lose Two-Thirds Of Obamacare Enrollees After Price Hikes
Published: October 28, 2025 by: Forbes
Sentiment: Negative
UnitedHealthcare, the nation's largest health insurer, said rate increases of more than 25% and “targeted service area” reductions could reduce its Obamacare customer base by about “two-thirds.”
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000